Pacciarini MA - Search Results

1

The new anthracycline 4-demethoxydaunorubicin by oral route in advanced pretreated breast cancer and melanoma. A pilot study.

Martoni A, Pacciarini MA, Pannuti F. Martoni A, et al. Among authors: pacciarini ma. Drugs Exp Clin Res. 1985;11(2):127-31. Drugs Exp Clin Res. 1985. PMID: 3915281 Clinical Trial.

2

A pilot study of oral idarubicin in metastatic melanoma.

Martoni A, Pacciarini MA, Piana E, Pannuti F. Martoni A, et al. Among authors: pacciarini ma. Chemioterapia. 1986 Dec;5(6):414-5. Chemioterapia. 1986. PMID: 3467876

3

Activity of 4-demethoxydaunorubicin by the oral route in advanced breast cancer.

Martoni A, Pacciarini MA, Pannuti F. Martoni A, et al. Among authors: pacciarini ma. Eur J Cancer Clin Oncol. 1985 Jul;21(7):803-6. doi: 10.1016/0277-5379(85)90218-4. Eur J Cancer Clin Oncol. 1985. PMID: 3862582

4

High-dose epirubicin for untreated patients with advanced tumours: a phase I study.

Martoni A, Melotti B, Guaraldi M, Pacciarini MA, Riva A, Pannuti F. Martoni A, et al. Among authors: pacciarini ma. Eur J Cancer. 1990;26(11-12):1137-40. doi: 10.1016/0277-5379(90)90270-4. Eur J Cancer. 1990. PMID: 1963544

5

Low dose oral administration of 4-demethoxydaunorubicin (idarubicin) in advanced cancer patients. A pharmacokinetic study.

Pannuti F, Camaggi CM, Strocchi E, Comparsi R, Angelelli B, Pacciarini MA. Pannuti F, et al. Among authors: pacciarini ma. Cancer Chemother Pharmacol. 1986;16(3):295-9. doi: 10.1007/BF00293996. Cancer Chemother Pharmacol. 1986. PMID: 3457647

6

Phase I trial of 4-demethoxydaunorubicin (idarubicin) with single oral doses.

Kaplan S, Sessa C, Willems Y, Pacciarini MA, Tamassia V, Cavalli F. Kaplan S, et al. Among authors: pacciarini ma. Invest New Drugs. 1984;2(3):281-6. doi: 10.1007/BF00175378. Invest New Drugs. 1984. PMID: 6595240

7

Idarubicin (4-demethoxydaunorubicin). A preliminary overview of preclinical and clinical studies.

Ganzina F, Pacciarini MA, Di Pietro N. Ganzina F, et al. Among authors: pacciarini ma. Invest New Drugs. 1986;4(1):85-105. doi: 10.1007/BF00172021. Invest New Drugs. 1986. PMID: 3516918 Review.

8

Pharmacokinetic study of intravenous and oral idarubicin in cancer patients.

Tamassia V, Pacciarini MA, Moro E, Piazza E, Vago G, Libretti A. Tamassia V, et al. Among authors: pacciarini ma. Int J Clin Pharmacol Res. 1987;7(5):419-26. Int J Clin Pharmacol Res. 1987. PMID: 3478310

9

Phase II study of esorubicin (4'-deoxydoxorubicin) in locally advanced or metastatic head and neck carcinoma.

Frustaci S, Gasparini G, Veronesi A, Tirelli U, Pacciarini MA, Crivellari D, Zagonel V, Monfardini S. Frustaci S, et al. Among authors: pacciarini ma. Invest New Drugs. 1987;5(3):307-9. doi: 10.1007/BF00175303. Invest New Drugs. 1987. PMID: 3667167

10

Preliminary observations on intravenous idarubicin (4-demethoxydaunorubicin) in the chronic and accelerated phase of chronic myelogenous leukemia.

Battista R, D'Emilio A, Vespignani M, Pacciarini MA, Dini E. Battista R, et al. Among authors: pacciarini ma. Tumori. 1986 Aug 31;72(4):389-93. doi: 10.1177/030089168607200408. Tumori. 1986. PMID: 3464125

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters